N. Kramer

Recurrent loss of heterozygosity correlates with clinical outcome in pancreatic neuroendocrine cancer

C. Print, C. Blenkiron, S. Grimmond, 2018, npj Genomic Medicine.

Consensus-Derived Quality Performance Indicators for Neuroendocrine Tumour Care

N. Pavlakis, S. Conroy, M. Michael, 2019, Journal of clinical medicine.

Recurrent loss of heterozygosity correlates with clinical outcome in pancreatic neuroendocrine cancer

C. Print, C. Blenkiron, S. Grimmond, 2017, bioRxiv.

Complex Patterns of Genomic Heterogeneity Identified in 42 Tumor Samples and ctDNA of a Pulmonary Atypical Carcinoid Patient

C. Print, C. Blenkiron, P. Tsai, 2022, Cancer research communications.

Survival of patients with small bowel neuroendocrine neoplasms in Auckland, Aotearoa New Zealand

C. Print, C. Harmston, B. Lawrence, 2022, ANZ journal of surgery.

Tailoring a rapid autopsy protocol to explore cancer evolution: a patient collaboration.

C. Print, C. Blenkiron, S. Stables, 2019, The New Zealand medical journal.

Can pathological reports of rectal cancer provide national quality indicators?

N. Kramer, C. Keane, I. Bissett, 2018, ANZ journal of surgery.